
### [MONDO:0018381](http://purl.obolibrary.org/obo/MONDO_0018381)
**Label:** osteochondrosis

**Subclasses:** [MONDO:0019967](http://purl.obolibrary.org/obo/MONDO_0019967) (Kienbock disease), [MONDO:0008142](http://purl.obolibrary.org/obo/MONDO_0008142) (Thiemann disease, familial form), [MONDO:0007885](http://purl.obolibrary.org/obo/MONDO_0007885) (Legg-Calve-Perthes disease), [MONDO:0004241](http://purl.obolibrary.org/obo/MONDO_0004241) (Osgood-Schlatter's disease), [MONDO:0010130](http://purl.obolibrary.org/obo/MONDO_0010130) (dihydropyrimidine dehydrogenase deficiency), [MONDO:0018385](http://purl.obolibrary.org/obo/MONDO_0018385) (osteochondrosis of genetic origin), [MONDO:0008410](http://purl.obolibrary.org/obo/MONDO_0008410) (Scheuermann's disease), [MONDO:0018929](http://purl.obolibrary.org/obo/MONDO_0018929) (medial condensing osteitis of the clavicle), [MONDO:0019970](http://purl.obolibrary.org/obo/MONDO_0019970) (Sinding-larsen-Johansson disease), [MONDO:0016086](http://purl.obolibrary.org/obo/MONDO_0016086) (osteochondritis of tarsal/metatarsal bone), [MONDO:0001359](http://purl.obolibrary.org/obo/MONDO_0001359) (Kohler's disease), [MONDO:0019969](http://purl.obolibrary.org/obo/MONDO_0019969) (Panner disease), 

**Mapped go classes:** [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0019483](http://purl.obolibrary.org/obo/GO_0019483) (beta-alanine biosynthetic process), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0006212](http://purl.obolibrary.org/obo/GO_0006212) (uracil catabolic process), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0006210](http://purl.obolibrary.org/obo/GO_0006210) (thymine catabolic process), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0004159](http://purl.obolibrary.org/obo/GO_0004159) (dihydrouracil dehydrogenase (NAD+) activity), [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding), [GO:0006214](http://purl.obolibrary.org/obo/GO_0006214) (thymidine catabolic process), [GO:0006208](http://purl.obolibrary.org/obo/GO_0006208) (pyrimidine nucleobase catabolic process), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0006145](http://purl.obolibrary.org/obo/GO_0006145) (purine nucleobase catabolic process), [GO:0006222](http://purl.obolibrary.org/obo/GO_0006222) (UMP biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0019860](http://purl.obolibrary.org/obo/GO_0019860) (uracil metabolic process), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0017113](http://purl.obolibrary.org/obo/GO_0017113) (dihydropyrimidine dehydrogenase (NADP+) activity), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding) 52.00%
- [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding) 52.00%
- [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding) 52.00%
- [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding) 52.00%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) 52.00%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.36%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.36%


